Besides the activation through the canonical and apoptotic pathways, lymphocyte-derived granzyme A cleaved GSDMB in human epithelial cells and led to a significant tumor clearance in co-treatment with an anti-PD-1-antibody in a murine tumor model (Zhou et al., 2020). Here, GZMA is linked to neoplasm.